Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, specializing in the development of innovative therapies targeting metabolic and endocrine disorders. The company's robust pipeline includes novel drug candidates designed to address significant unmet medical needs, with a focus on conditions such as obesity and liver disease. Leveraging its proprietary drug development platforms and expertise in metabolic pathways, Viking aims to enhance patient outcomes through groundbreaking therapeutic solutions. As it progresses through clinical trials, the company is well-positioned to make a notable impact in the biopharmaceutical landscape.